Condition
Hepatitis C Virus (HCV)
ClinicalTrials.gov condition label
Advertisement
Clinical trials
6 shownCalifornia MEPS HubNCT07433985 · 2025-12-01
RECRUITINGEnhancing Uptake of Needle and Syringe Programs in Canadian Federal PrisonsNCT07122219 · 2024-10-01
RECRUITINGAssessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record SystemNCT07406490 · 2026-07-01
NOT_YET_RECRUITINGMAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR CongoNCT07388979 · 2026-03-01
NOT_YET_RECRUITINGA Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionNCT03222583 · 2017-10-04
COMPLETEDEfficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionNCT03235349 · 2017-09-29
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
NOT_YET_RECRUITING2
RECRUITING2
Phase mix
NA2
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.